Prevail Therapeutics, the gene therapy-focused subsidiary of Eli Lilly announced a partnership with biotechnology company Capsida Biotherapeutics to develop genetic medicines for central nervous system diseases.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,